eGFR discrepancy

Biomarker

1 paper2 findings

  • Humans1

Associations

2

Frailty

downin humans1OR 0.851

1 study
  1. eGFR discrepancy is associated with frailty in humans (OR 0.851 per 1-SD higher discrepancy; 95% CI 0.804–0.900).

    “lower odds of frailty (OR, 0.851; 95% CI, 0.804-0.900; P < 0.001).”

    HumansFrailty defined as Frailty Index ≥0.251-SD higher eGFR discrepancy2011–2013 and 2015–201853.4% femalesn = 11,174

    Association of eGFR Discrepancy With Subsequent Frailty in Middle-Aged and Older Adults

    Journal of nephrology14 Oct 2026

32-item Frailty Index

downin humans1

1 study
  1. eGFR discrepancy is associated with 32-item Frailty Index in humans (β -0.503 per 1-SD higher discrepancy; 95% CI -0.678 to -0.328).

    “A 1-SD higher discrepancy was associated with a lower follow-up Frailty Index (β, -0.503; 95% CI, -0.678 to -0.328; P < 0.001)”

    Humans1-SD higher eGFR discrepancy2011–2013 and 2015–201853.4% femalesn = 11,174

    Association of eGFR Discrepancy With Subsequent Frailty in Middle-Aged and Older Adults

    Journal of nephrology14 Oct 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 in 12 months